Outcomes After Virologic Failure of First-Line ART in South Africa
dc.contributor.author | Murphy, Richard A | |
dc.contributor.author | Sunpath, Henry | |
dc.contributor.author | Lu, Zhigang | |
dc.contributor.author | Chelin, Neville | |
dc.contributor.author | Losina, Elena | |
dc.contributor.author | Gordon, Michelle | |
dc.contributor.author | Ross, Douglas | |
dc.contributor.author | Ewusi, Aba D | |
dc.contributor.author | Matthews, Lynn T | |
dc.contributor.author | Kuritzkes, Daniel R | |
dc.contributor.author | Marconi, Vincent C | |
dc.date.accessioned | 2012-12-11T23:38:27Z | |
dc.date.available | 2012-12-11T23:38:27Z | |
dc.date.issued | 2010-04-24 | |
dc.date.submitted | 2011-03-22 | |
dc.identifier.citation | AIDS;2010;24(7):1007-12 | en |
dc.identifier.issn | 1473-5571 | |
dc.identifier.pmid | 20397305 | |
dc.identifier.uri | http://hdl.handle.net/10144/255398 | |
dc.description | Article approval pending | |
dc.description.abstract | To determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART). | |
dc.language.iso | en | en |
dc.relation.url | http://journals.lww.com/aidsonline/Abstract/2010/04240/Outcomes_after_virologic_failure_of_first_line_ART.9.aspx | en |
dc.rights | Published by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluwer | en |
dc.subject.mesh | Adult | en |
dc.subject.mesh | Anti-HIV Agents | en |
dc.subject.mesh | Anti-Retroviral Agents | en |
dc.subject.mesh | CD4 Lymphocyte Count | en |
dc.subject.mesh | Drug Resistance, Viral | en |
dc.subject.mesh | Female | en |
dc.subject.mesh | Genotype | en |
dc.subject.mesh | HIV Infections | en |
dc.subject.mesh | HIV-1 | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Male | en |
dc.subject.mesh | Middle Aged | en |
dc.subject.mesh | Mutation | en |
dc.subject.mesh | Prospective Studies | en |
dc.subject.mesh | South Africa | en |
dc.subject.mesh | Treatment Failure | en |
dc.subject.mesh | Viral Load | en |
dc.title | Outcomes After Virologic Failure of First-Line ART in South Africa | en |
dc.type | Article | en |
dc.contributor.department | Operational Support Unit, Doctors Without Borders, New York, New York; McCord Hospital, Durban, South Africa; Massachusetts General Hospital, Boston, Massachusetts, USA; Nelson Mandela School of Medicine, Durban; St. Mary’s Hospital, Mariannhill, South Africa; Harvard Medical School; Division of Infectious Diseases, Beth Israel Deaconess Medical Center; Section of Retroviral Therapeutics, Brigham and Women’s Hospital, Boston, Massachusetts; Infectious Disease Service, San Antonio Military Medical Center, Fort Sam Houston, Texas; Emory University School of Medicine, Atlanta, Georgia, USA | en |
dc.identifier.journal | AIDS | en |
refterms.dateFOA | 2019-03-04T10:07:45Z | |
html.description.abstract | To determine initial 24-week outcomes among prospectively enrolled patients with failure of initial antiretroviral therapy (ART). |